Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

strating a clinical benefit, such as improvement in disease-related symptoms or increased survival

Important Safety Information(1)

Severe (NCI Grades 3/4) lab abnormalities (400 mg/day; 600 mg/day)- including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia (0%; 1%), and hepatotoxicity (6%; 8%)-and severe adverse experiences (NCI Grades 3/4), including severe fluid retention (eg, pleural effusion or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%), and musculoskeletal pain (6%; 1%) were reported among patients receiving Gleevec

Some patients (5%) were reported to have severe GI bleeds and/or intratumoral bleeds. GI tumor sites may have been the source of GI bleeds

Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and gastrointestinal (GI) perforation

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other comorbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction

Dose adjustments ma
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/18/2014)... Nov. 18, 2014 Respiratory Motion and IMI ... medical device and services providers in Japan ... Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. As ... are working together to connect the clinical community in ... history of bringing innovative medical devices and new technology ...
(Date:11/18/2014)... 18, 2014 Investor-Edge has initiated coverage ... ), Geron Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals ... GALE ), and XOMA Corporation (NASDAQ: ... accessed at: http://investor-edge.com/register . The US markets ... as the Dow Jones Industrial Average finished at 17,647.75, up ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
(Date:11/21/2014)... The cost of diabetes care in the United States ... more than $322 billion annually, a new report shows. ... prediabetes care, which have risen 74 percent, and undiagnosed ... In 2012, excess medical costs and lost productivity ... American. That total includes $244 billion in medical costs ...
(Date:11/21/2014)... 2014 Richard Wolfe, co-founder and ... present advanced benefits administration strategies during the Game ... Leadership Summit. This Game Changer breakout session enables ... present cutting-edge solutions and best practices to top ... real-time data exchange between health and welfare benefits ...
(Date:11/21/2014)... Kansas City, Mo (PRWEB) November 21, 2014 ... has received the Get With The Guidelines®–Heart Failure ... improvement measures outlined by the American Heart Association/American ... guidelines for heart failure patients. , Get With ... that helps hospital teams provide the most up-to-date, ...
(Date:11/21/2014)... NJ (PRWEB) November 21, 2014 The ... homemade, high calorie dishes, plenty of gravy and a ... could be the best time of year to begin ... Diet Doc has uncovered the secret to losing unhealthy, ... the fattening holiday recipes. , The insight to Diet ...
(Date:11/21/2014)... Midway through the research period for the 2015 ... of Health Plans, preliminary data shows volatility in the ... is a comprehensive resource with enrollment data and contact ... 2015 edition will be available in February. ... Division, the company’s exclusive in-house research team, have identified ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2
... , McALLEN, Texas, Dec. 3 The Ensign ... it has acquired three Texas skilled nursing facilities: the ... the 100-bed Alta Vista Rehabilitation & Healthcare in Brownsville; ... The acquisitions were effective December 1, 2009. , (Logo: ...
... , MINNEAPOLIS, Dec. 3 The American Association of Poison ... Minneapolis, Minnesota as an accredited poison control center - a ... AAPCC places the Hennepin Regional Poison Center among 58 accredited ... major accomplishment. It means we have met the national standards ...
... , NEW YORK, Dec. ... is available in its catalogue: , Point of Care ... review and analysis of the point of care (POC) diagnostics ... POC diagnostics industry , Covers federal regulation of POC ...
... , Statement by John Gay, Executive Director and ... to a new campaign launched today by the U.S. ... marketplace of "rogue" marketers selling steroids as dietary supplements, ... association representing retailers and manufacturers of dietary supplements and ...
... finds rising incidence of obesity could counter recent increases in ... health of the U.S. population has improved over the past ... but a new study suggests those gains might soon be ... level off or drop. , If current trends in both ...
... added batches now available, many more to come, NIH director ... stem cell lines have been added to the pool that ... lines will soon be made available, U.S. health officials announced ... lines approved for research funded by the U.S. National Institutes ...
Cached Medicine News:Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3
Large: 22 x 25 mm, 0.9 x 1.0 inches. With holes. For support of the orbital rim following enucleation. Available in methylmethacrylate....
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches....
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
Medicine Products: